medicalxpress - In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes. Results of the study are published in The Journal of Nutrition.
#healthcare #publichealth #infectiousdisease #longcovid #clinicaltrials #nutrition #vitamind #supplements
Monday, March 16, 2026, 1:22 am / permalink 20790 / 2 stories in 17 hrs
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (14 hrs)
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (15 hrs)
Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (18 hrs)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.